Biosyent Inc - Insider Selling Source: INK Research September 24, 2014
Sep 18/14 Larson, Douglas Robert Direct Ownership Public market sale Common Shares 12.29 -1,000 -5.6% 17,000
Sep 17/14 Wakefield, Milt Direct Ownership Public market sale Common Shares 11.51 - 11.53 -2,000 -3.1% 62,500
Sep 15/14 Larson, Douglas Robert Direct Ownership Public market sale Common Shares 11.65 - 11.70 -2,000 -10.0% 18,000
I think the above may have been the catalyst that triggered the recent drop. Insider selling, triggered panic selling, and then more panic selling. Also the recent overall TSX market drop may have played a factor as well. The P/E Ratio of RX is also pretty high at about P/E 58.44 according to Google Finance. I'm not too familar with Canadian phaurameticals, what is the industries average P/E? Do they usually run this high of a P/E?